Literature DB >> 12402137

[Bullous pemphigoid manifesting as dyshidrotic eczema and prurigo nodularis].

B Braun1, B Baima, M Sticherling.   

Abstract

A 63-year-old woman presented simultaneously with two rare forms of bullous pemphigoid. Initially she had a dyshidrotic palmoplantar eczema. Repeated epicutaneous patch tests ruled out a type IV allergic reaction to common allergens. Six months later the patient developed disseminated pruritic nodules. After 4.5 years she then demonstrated scattered bullae within erythematous plaques indicative of bullous pemphigoid. A skin biopsy showed linear IgG and IgM as well as C3 deposits at the dermo-epidermal junction and circulating autoantibodies against the basement membrane could be found in serum. Accordingly, the diagnosis of bullous pemphigoid was made. In retrospect, the vesicular palmoplantar eczema and pruritic nodules could be interpreted in this case as early manifestations of bullous pemphigoid. We recommend that in patients with persistent pruritic skin lesions, which are resistant to standard therapy, bullous pemphigoid should be excluded by adequate immunological examinations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12402137     DOI: 10.1007/s00105-002-0348-6

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  4 in total

1.  [Bullous pemphigoid: first manifestation under a picture of prurigo simplex subacuta].

Authors:  N Hodzic-Avdagic; G Reinerth; J Reifenberger; R Kruse; D Bruch-Gerharz
Journal:  Hautarzt       Date:  2007-04       Impact factor: 0.751

2.  [Pemphigoid nodularis triggered by hypereosinophilic syndrome?].

Authors:  V von Felbert; D Simon; L Braathen; T Hunziker
Journal:  Hautarzt       Date:  2006-05       Impact factor: 0.751

Review 3.  Dyshidrosiform Bullous Pemphigoid.

Authors:  Philip R Cohen
Journal:  Medicina (Kaunas)       Date:  2021-04-20       Impact factor: 2.430

4.  Dyshidrosiform Bullous Pemphigoid: Case Reports and Review.

Authors:  Philip R Cohen
Journal:  Cureus       Date:  2020-01-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.